JP2008505983A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008505983A5 JP2008505983A5 JP2007527402A JP2007527402A JP2008505983A5 JP 2008505983 A5 JP2008505983 A5 JP 2008505983A5 JP 2007527402 A JP2007527402 A JP 2007527402A JP 2007527402 A JP2007527402 A JP 2007527402A JP 2008505983 A5 JP2008505983 A5 JP 2008505983A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- subject
- composition
- compound according
- imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 26
- 238000000034 method Methods 0.000 claims 14
- 229910021645 metal ion Inorganic materials 0.000 claims 12
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 238000003384 imaging method Methods 0.000 claims 8
- 201000011510 cancer Diseases 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 4
- 230000005855 radiation Effects 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 230000001678 irradiating effect Effects 0.000 claims 3
- 238000002595 magnetic resonance imaging Methods 0.000 claims 3
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 3
- 238000002600 positron emission tomography Methods 0.000 claims 3
- 238000002603 single-photon emission computed tomography Methods 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 2
- 229910052688 Gadolinium Inorganic materials 0.000 claims 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- ZIHQUWYJSTVYAT-UHFFFAOYSA-N [NH-][N+]([O-])=O Chemical compound [NH-][N+]([O-])=O ZIHQUWYJSTVYAT-UHFFFAOYSA-N 0.000 claims 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 229910052788 barium Inorganic materials 0.000 claims 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims 2
- 229910052796 boron Inorganic materials 0.000 claims 2
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 229910052804 chromium Inorganic materials 0.000 claims 2
- 239000011651 chromium Substances 0.000 claims 2
- 229910017052 cobalt Inorganic materials 0.000 claims 2
- 239000010941 cobalt Substances 0.000 claims 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 2
- 229910052802 copper Inorganic materials 0.000 claims 2
- 239000010949 copper Substances 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims 2
- 229910052732 germanium Inorganic materials 0.000 claims 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 2
- 229910052737 gold Inorganic materials 0.000 claims 2
- 239000010931 gold Substances 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 229910052738 indium Inorganic materials 0.000 claims 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 2
- 229910052742 iron Inorganic materials 0.000 claims 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical group [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 229910052759 nickel Inorganic materials 0.000 claims 2
- 230000005298 paramagnetic effect Effects 0.000 claims 2
- 238000002428 photodynamic therapy Methods 0.000 claims 2
- 229910052697 platinum Inorganic materials 0.000 claims 2
- -1 porphyrin compound Chemical class 0.000 claims 2
- 229910052707 ruthenium Inorganic materials 0.000 claims 2
- 229910052713 technetium Inorganic materials 0.000 claims 2
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 claims 2
- 229910052718 tin Inorganic materials 0.000 claims 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims 2
- 229910052721 tungsten Inorganic materials 0.000 claims 2
- 239000010937 tungsten Substances 0.000 claims 2
- 229910052720 vanadium Inorganic materials 0.000 claims 2
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical group [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 claims 2
- 229910052727 yttrium Inorganic materials 0.000 claims 2
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 230000002902 bimodal effect Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/848,741 US6995260B2 (en) | 2004-05-20 | 2004-05-20 | Carboranylporphyrins and uses thereof |
| PCT/US2005/017358 WO2006088476A2 (en) | 2004-05-20 | 2005-05-17 | Carboranylporphyrins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008505983A JP2008505983A (ja) | 2008-02-28 |
| JP2008505983A5 true JP2008505983A5 (enExample) | 2008-07-03 |
Family
ID=35375345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007527402A Pending JP2008505983A (ja) | 2004-05-20 | 2005-05-17 | カルボラニルポルフィリン及びそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6995260B2 (enExample) |
| EP (1) | EP1753468A4 (enExample) |
| JP (1) | JP2008505983A (enExample) |
| KR (1) | KR20070026552A (enExample) |
| CN (1) | CN1968705A (enExample) |
| AU (1) | AU2005327597B2 (enExample) |
| CA (1) | CA2567468A1 (enExample) |
| IL (1) | IL179497A0 (enExample) |
| NO (1) | NO20065858L (enExample) |
| NZ (1) | NZ551732A (enExample) |
| WO (1) | WO2006088476A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2397067B (en) * | 2002-12-23 | 2005-05-11 | Destiny Pharma Ltd | Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation |
| US20070093463A1 (en) * | 2004-05-20 | 2007-04-26 | Brookhaven Science Associates, Llc | Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy |
| GB2415372A (en) | 2004-06-23 | 2005-12-28 | Destiny Pharma Ltd | Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent |
| GB0427589D0 (en) | 2004-12-16 | 2005-01-19 | Psimei Pharmaceuticals Plc | Process for the preparation of a substituted porphyrin |
| US8287839B2 (en) * | 2006-12-04 | 2012-10-16 | Brookhaven Science Associates, Llc | Carboranylporphyrins and uses thereof |
| WO2008102669A1 (ja) * | 2007-02-19 | 2008-08-28 | Rei Medical Co., Ltd. | 新規な糖連結クロリン誘導体及びその製造方法 |
| US8444953B2 (en) * | 2007-03-22 | 2013-05-21 | Brookhaven Science Associates, Llc | Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof |
| US20080279781A1 (en) * | 2007-05-10 | 2008-11-13 | Brookhaven Science Associates, Llc | Glycosylated Carboranylporphyrins and Uses Thereof |
| JP5745415B2 (ja) * | 2009-09-17 | 2015-07-08 | 国立大学法人九州大学 | ポルフィリン化合物 |
| WO2011050575A1 (en) * | 2009-10-28 | 2011-05-05 | The University Of Hong Kong | Hydroxy-substituted gold(iii) porphyrin complexes as histone deacetylase inhibitors |
| CN102268003B (zh) * | 2011-06-16 | 2013-10-30 | 扬州大学 | 不对称多取代卟啉金(iii)类抗癌化合物及其制备方法 |
| GB201221125D0 (en) * | 2012-11-23 | 2013-01-09 | Morex Dev Partners Llp | Pharmaceutial formulations |
| KR102885276B1 (ko) * | 2021-07-13 | 2025-11-11 | 삼성에스디아이 주식회사 | 염료, 이를 포함하는 조성물, 필름, 광학 부재 및 디스플레이 장치 |
| CN114015066B (zh) * | 2021-11-12 | 2022-08-12 | 北京大学 | 共价有机框架材料、其制备方法和用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783529A (en) * | 1985-12-03 | 1988-11-08 | Research Corporation Technologies | Rapid synthesis of radiolabeled porphyrin complexes for medical application |
| US5162231A (en) * | 1989-10-25 | 1992-11-10 | Cole Dean A | Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung |
| US4959356A (en) * | 1989-05-26 | 1990-09-25 | The United States Of America As Represented By The United States Department Of Energy | Porphyrins for boron neutron capture therapy |
| FR2656866B1 (fr) * | 1990-01-10 | 1992-05-15 | Cis Bio Int | Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant. |
| US5654423A (en) * | 1990-11-21 | 1997-08-05 | Regents Of The University Of California | Boronated metalloporphyrine and therapeutic methods |
| US5149801A (en) * | 1990-11-21 | 1992-09-22 | The Regents Of The University Of California | Boronated porphyrin compounds |
| US5312896A (en) * | 1992-10-09 | 1994-05-17 | Sri International | Metal ion porphyrin-containing poly(imide) |
| DE4305523A1 (de) * | 1993-02-17 | 1994-08-18 | Diagnostikforschung Inst | Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
| US5563132A (en) * | 1994-06-21 | 1996-10-08 | Bodaness; Richard S. | Two-step cancer treatment method |
| US5648485A (en) * | 1994-10-26 | 1997-07-15 | University Of British Columbia | β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
| US5877165A (en) * | 1995-11-02 | 1999-03-02 | Brookhaven Science Associates | Boronated porhyrins and methods for their use |
| US5955586A (en) * | 1996-03-22 | 1999-09-21 | Sessler; Jonathan L. | Highly boronated derivatives of texaphyrins |
| WO1998030102A1 (en) * | 1997-01-09 | 1998-07-16 | Emory University | Non-iron metalloporphyrins and methods of use |
| US6010805A (en) * | 1998-05-26 | 2000-01-04 | United States Of America As Represented By The Secretary Of The Air Force | Ion conducting electrolyte material containing a lithium porphyrin complex |
| AU2001274827A1 (en) | 2000-05-09 | 2001-11-20 | The Regents Of The University Of California | Porphyrin-based neutron capture agents for cancer therapy |
| US6566517B2 (en) * | 2001-06-06 | 2003-05-20 | Brookhaven Science Associates, Llc | Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy |
| US7087214B2 (en) * | 2002-02-01 | 2006-08-08 | Zentaris Gmbh | Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| GB0222945D0 (en) * | 2002-10-03 | 2002-11-13 | Psimei Pharmaceuticals Plc | Therapeutic compositions |
-
2004
- 2004-05-20 US US10/848,741 patent/US6995260B2/en not_active Expired - Fee Related
-
2005
- 2005-05-17 CN CNA2005800203414A patent/CN1968705A/zh active Pending
- 2005-05-17 KR KR1020067025283A patent/KR20070026552A/ko not_active Ceased
- 2005-05-17 CA CA002567468A patent/CA2567468A1/en not_active Abandoned
- 2005-05-17 EP EP05856727A patent/EP1753468A4/en not_active Withdrawn
- 2005-05-17 NZ NZ551732A patent/NZ551732A/en not_active IP Right Cessation
- 2005-05-17 WO PCT/US2005/017358 patent/WO2006088476A2/en not_active Ceased
- 2005-05-17 JP JP2007527402A patent/JP2008505983A/ja active Pending
- 2005-05-17 AU AU2005327597A patent/AU2005327597B2/en not_active Ceased
-
2006
- 2006-11-22 IL IL179497A patent/IL179497A0/en unknown
- 2006-12-15 NO NO20065858A patent/NO20065858L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010511704A5 (enExample) | ||
| RU2009121323A (ru) | Карборанилпорферины и их применение | |
| JP2008505983A5 (enExample) | ||
| Aihara et al. | First clinical case of boron neutron capture therapy for head and neck malignancies using 18F‐BPA PET | |
| Miyatake et al. | Boron neutron capture therapy for malignant brain tumors | |
| Masunaga et al. | The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy | |
| CN1279907C (zh) | 新的金属卟啉化合物及其在放射疗法中用作放射增敏剂的用途 | |
| Zou et al. | 68Ga-labeled magnetic-NIR persistent luminescent hybrid mesoporous nanoparticles for multimodal imaging-guided chemotherapy and photodynamic therapy | |
| Fukuda et al. | Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor | |
| Yuan et al. | Boron neutron capture therapy of cancer: Critical issues and future prospects | |
| JP2008504365A5 (enExample) | ||
| Garabalino et al. | Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model | |
| Bianfei et al. | Application of Cherenkov radiation in tumor imaging and treatment | |
| Wei et al. | X-ray/γ-ray/Ultrasound-Activated Persistent Luminescence Phosphors for Deep Tissue Bioimaging and Therapy | |
| JP6170147B2 (ja) | 癌治療 | |
| Fazaeli et al. | 68Ga CdTe/CdS fluorescent quantum dots for detection of tumors: investigation on the effect of nanoparticle size on stability and in vivo pharmacokinetics | |
| Golshani et al. | Gadolinium neutron capture therapy: Calculation of 157Gd kerma factor and a dosimetry study using MCNP Monte Carlo code | |
| CA2572287A1 (en) | Carboranylporphyrins and uses thereof | |
| Fujibayashi et al. | Imaging and therapy against hypoxic tumors with 64Cu-ATSM | |
| Brandão et al. | Intracavitary moderator balloon combined with 252Cf brachytherapy and boron neutron capture therapy, improving dosimetry in brain tumour and infiltrations | |
| JP2014177421A (ja) | 陽子線治療用増感剤、及びそれを用いた陽子線治療法 | |
| McGovern et al. | Case report of a dog treated with radioactive iodine (I131) and stereotactic body radiation therapy (SBRT) for metastatic ectopic thyroid carcinoma | |
| Masunaga et al. | Effect of a change in reactor power on response of murine solid tumors in vivo, referring to impact on quiescent tumor cell population | |
| Ajlouni | Radiotherapy by Neutron-Irradiated Nanoparticles | |
| Young | AgTPPS (4) enhanced brachytherapy as a treatment for inoperable brain tumors |